| Literature DB >> 31444470 |
Keiichiro Suzuki1,2,3, Mako Yamamoto4, Reyna Hernandez-Benitez4, Zhe Li5, Christopher Wei5, Rupa Devi Soligalla4,6, Emi Aizawa4,7, Fumiyuki Hatanaka4, Masakazu Kurita4,6, Pradeep Reddy4, Alejandro Ocampo4, Tomoaki Hishida4, Masahiro Sakurai4,6, Amy N Nemeth4, Estrella Nuñez Delicado6, Josep M Campistol8, Pierre Magistretti9, Pedro Guillen10, Concepcion Rodriguez Esteban4, Jianhui Gong11,12,13,14, Yilin Yuan11,12,13, Ying Gu11,12,13, Guang-Hui Liu15, Carlos López-Otín16, Jun Wu6,17,18, Kun Zhang5, Juan Carlos Izpisua Belmonte19.
Abstract
In vivo genome editing represents a powerful strategy for both understanding basic biology and treating inherited diseases. However, it remains a challenge to develop universal and efficient in vivo genome-editing tools for tissues that comprise diverse cell types in either a dividing or non-dividing state. Here, we describe a versatile in vivo gene knock-in methodology that enables the targeting of a broad range of mutations and cell types through the insertion of a minigene at an intron of the target gene locus using an intracellularly linearized single homology arm donor. As a proof-of-concept, we focused on a mouse model of premature-aging caused by a dominant point mutation, which is difficult to repair using existing in vivo genome-editing tools. Systemic treatment using our new method ameliorated aging-associated phenotypes and extended animal lifespan, thus highlighting the potential of this methodology for a broad range of in vivo genome-editing applications.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31444470 PMCID: PMC6796851 DOI: 10.1038/s41422-019-0213-0
Source DB: PubMed Journal: Cell Res ISSN: 1001-0602 Impact factor: 25.617